An officer at the Portland Police Bureau is opening up about her experience with mental health in a new memoir.

The annual awards show will anoint a best podcast for the first time this year, a sign of the industry’s increasing status in ...

Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026. On December 18, Truist lowered the firm’s price target on Insulet to $390 from $412 with a Buy rating on the shares.

Fintel reports that on December 18, 2025, Truist Securities maintained coverage of Insulet (NasdaqGS:PODD) with a Buy recommendation. Analyst Price Forecast Suggests 31.68% Upside As of December 5, ...

Insulet (PODD) has been quietly recalibrating after a choppy past month, with the stock down around 11% even as its year to date gain sits in the mid teens, inviting a closer look. See our latest ...

Fintel reports that on November 19, 2025, UBS upgraded their outlook for Insulet (NasdaqGS:PODD) from Neutral to Buy. Analyst Price Forecast Suggests 9.42% Upside As of November 17, 2025, the average ...

(Photo by Kirk Mckoy/Los Angeles Times via Getty Images) When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: ...

Insulet Corporation (NASDAQ:PODD) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 10, RBC Capital raised the price target on Insulet to $365 from $350 and kept an ...

Anil R. Diwan, PhD, President and Executive Chairman of the Company will provide an update on the Company, its Drug Pipeline and Platform Technologies available for licensing. NanoViricides' Current ...